Close
Close
Wolverine Blend (BPC-157 / Thymosin Beta-4)

Wolverine Blend (BPC-157 / Thymosin Beta-4) 3-Month Membership Program

$1,350.00

4.9 Avg. Rating

1000+ Reviews

  • Follow-up Exam
  • Lab Review
  • Dose Adjustments
  • Certificate of Authenticity
  • 503A Pharmacies
  • 99% Pure
  • US-based Peptides
The Wolverine Blend is a nickname many patients have heard used for a combination of two peptides, BPC-157 and Thymosin Beta-4, that are often discussed together in the context of tissue recovery. The name itself comes from popular culture, referencing a fictional character known for rapid healing, but it’s important for patients to understand that this playful nickname doesn’t reflect a scientifically established outcome.
BPC-157 is a synthetic peptide based on a fragment of a protective protein naturally found in human gastric juice, and it has been studied for its potential role in supporting tissue and gut health. Thymosin Beta-4 is a naturally occurring protein found throughout the body that plays a role in cell movement and structural organization within cells, a process relevant to how tissues repair themselves after injury.
Patients commonly ask about this combination because they’re hoping for broader recovery support than either peptide might offer alone, since the two peptides are studied through different, complementary mechanisms. It’s important to understand upfront that this specific two-peptide combination has not been directly studied together in dedicated human research, and the individual peptides themselves are still working through an evolving research and regulatory landscape.
This page provides an honest look at what’s known about each component and about the combination as a concept, so you can have a realistic, informed conversation with your provider before considering this therapy.
To understand this combination, it helps to think of tissue repair as needing two different kinds of support: good blood flow and organized cellular movement. BPC-157 is studied for its potential role in supporting new blood vessel growth to injured tissue, essentially helping deliver oxygen and nutrients where they’re needed. Thymosin Beta-4 works through a different pathway, interacting with a structural protein inside cells called actin, which influences how cells move and organize themselves, a process important for cells traveling to an injury site to begin repair. Because these two peptides are studied through different mechanisms, some providers and researchers have proposed that combining them might offer complementary support: one focused on circulation to the injury, and the other focused on the cellular movement needed to carry out repair. It’s important to understand that this rationale is largely theoretical, built by combining what’s known about each peptide separately rather than from direct research on the combination itself. As with any combination therapy, this is a reasonable hypothesis worth discussing with your provider, but it isn’t the same as proven, established synergy.
  • Is currently being studied for its potential role in supporting tissue repair through two different, complementary biological pathways
  • May be of interest to patients exploring more comprehensive recovery support after physical activity or minor soft-tissue strain
  • Has shown promise in research, when each peptide is considered individually, for supporting blood vessel growth and cellular movement relevant to tissue healing
  • Is being explored by some providers as a broader recovery-support option, though the combination itself lacks dedicated human research
Because this specific combination has not been directly studied in human clinical trials, these potential benefits should be understood as a reasonable but still theoretical extension of each peptide’s individual research, not a proven combined effect.
Patients who commonly ask about the Wolverine Blend include those interested in:
  • Athletic recovery, particularly active adults looking for more comprehensive peptide-based recovery support
  • Muscle and connective tissue support, for patients recovering from strain or overuse
  • Wellness optimization, for patients working with a provider on a broader recovery and resilience plan
This combination is not appropriate for everyone, and given the limited human research on both components, and the lack of direct research on the combination itself, it requires a particularly thorough and honest conversation with a licensed provider before starting.
Each component of this blend has its own body of research. BPC-157 has an extensive animal and laboratory research history exploring tissue repair and digestive tract protection, though human clinical trial data remains limited, as discussed in more detail on our dedicated BPC-157 page. Thymosin Beta-4 and its synthetic form have also been studied in laboratory and animal research related to cell migration, wound healing, and tissue regeneration across several organ systems, including skin, muscle, and cardiac tissue. It’s important to be transparent that no dedicated human clinical trials have examined the specific combination of BPC-157 and Thymosin Beta-4 together. The rationale for combining them comes from extrapolating each peptide’s individual, largely preclinical research rather than from direct evidence of a combined effect in humans. Additionally, patients should know that Thymosin Beta-4-related substances have drawn specific regulatory attention. Sports anti-doping authorities classify Thymosin Beta-4 and its derivatives as prohibited substances, which is an important consideration for competitive athletes. Both peptides have also seen their pharmacy compounding status evolve over time as the FDA continues to review available data. Because of all these factors, this combination should be approached as an area of ongoing, evolving research and regulation rather than an established, well-studied therapy.
Available research on each individual peptide generally describes mild side effect profiles, most commonly limited to injection site reactions. However, because human safety data on both peptides is limited, and because no dedicated human research exists on the specific combination, safety information for this blend should be considered incomplete rather than fully established. This combination requires an especially thorough conversation with your provider, including a review of your full medical history and any relevant considerations, such as competitive athletic status, given the anti-doping classification of Thymosin Beta-4. Patients with certain active health conditions may not be appropriate candidates. This is not a complete list of contraindications, and only a licensed provider can help you understand whether this combination is a reasonable option to explore. Ongoing medical supervision is especially important given the still-evolving safety, research, and regulatory picture surrounding this combination. Patients should never source or use these peptides outside of a properly supervised medical relationship.

What does the Wolverine Blend do?

It combines BPC-157 and Thymosin Beta-4, two peptides studied individually for their potential roles in tissue repair, through complementary mechanisms involving blood flow and cellular movement.

Is the Wolverine Blend FDA-approved?

No. Neither BPC-157 nor Thymosin Beta-4 has FDA approval, and their status for pharmacy compounding has changed over time as regulators continue to review available data.

How long before I may notice changes?

Responses vary considerably, and because dedicated human research on this combination doesn’t exist, there is no well-established timeline for expected results.

Is it an injection?

Yes, both components are typically administered as subcutaneous injections.

Can it be combined with other peptides?

This should always be discussed with your provider, who can evaluate your full treatment plan and goals.

Can it be combined with GLP-1 medications?

This should be discussed individually with your provider as part of your overall treatment plan.

Will I need lab work?

Your provider may recommend baseline evaluation as part of a thorough, individualized approach to this combination therapy.

Who should avoid this peptide combination?

Patients with certain active health conditions, and competitive athletes subject to anti-doping testing, should have a particularly careful conversation with their provider, as Thymosin Beta-4 is a prohibited substance in many sports contexts.

How long do patients typically remain on therapy?

Treatment length varies by individual goals, and given the evolving evidence base, your provider will help determine a reasonable, individualized plan.

Is a consultation required?

Yes. A telehealth consultation with a licensed medical provider is required before starting the Wolverine Blend or any peptide therapy at SevenHealth.
Every peptide treatment program at SevenHealth is built around comprehensive, individualized medical care. When you begin therapy, your program includes:
  • An initial telehealth medical history and comprehensive evaluation with a licensed medical provider
  • Review of previous laboratory results when available, or recommendations for laboratory testing when medically appropriate
  • Personalized treatment recommendations based on your medical history and goals
  • Three months of prescribed peptide therapy when medically appropriate
  • A customized dosing and titration schedule specific to your prescribed peptide
  • A comprehensive follow-up appointment approximately three months after starting treatment
  • Review of progress, discussion of results, treatment adjustments if medically appropriate, and continued provider guidance
  • Ongoing provider oversight throughout your treatment program
  • No additional fees for appointments included within the treatment program
  • No additional fees for laboratory review as part of your treatment
Our goal is to make your experience with peptide therapy simple, transparent, and medically supervised from your very first consultation through every follow-up appointment. Given the evolving research and regulatory picture surrounding this combination, your provider will keep you informed of current availability and realistic expectations throughout your care.
Patients choose SevenHealth because we focus on individualized, medically supervised care rather than one-size-fits-all protocols. Every treatment plan is built around your specific health history and goals, and every prescription is overseen by a licensed medical provider from start to finish. We work with FDA-registered 503A U.S. compounding pharmacies that follow applicable quality standards, so you can feel confident in the source and handling of your prescribed peptide therapy, to the extent current regulations allow. Dosing is guided by your provider, not guesswork, and every program includes a three-month follow-up to review your progress and make adjustments if needed. We also believe in transparent pricing and honest education. There are no surprise appointment fees or lab review fees hidden within your treatment program, and we believe in giving patients a clear, accurate picture of where the science and regulatory landscape currently stand.
  • The Wolverine Blend combines BPC-157 and Thymosin Beta-4, two peptides studied for potential roles in tissue repair through different mechanisms.
  • The nickname comes from popular culture and does not reflect a scientifically proven healing outcome.
  • No dedicated human research exists on this specific combination; the rationale is extrapolated from each peptide’s individual, largely preclinical research.
  • Thymosin Beta-4 is classified as a prohibited substance in many competitive sports contexts.
  • Both peptides’ regulatory status for pharmacy compounding has changed over time and continues to be reviewed.
  • Available safety data for each individual peptide suggests mild side effects, but comprehensive data on the combination is not available.
  • This combination requires an especially thorough, honest conversation with your provider.
  • SevenHealth includes an initial evaluation, personalized dosing, lab review, and a three-month follow-up in every treatment program.

Educational Disclaimer

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Peptide therapy should only be used under the supervision of a licensed healthcare provider after an appropriate medical evaluation. Individual results may vary.

$100 OFF GLP-1 Injectable Plans for New Members ! CODE: